Product Information

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Somerset Therapeutics, LLC, priced at $2.1633 per ML under NDC 70069001925. Its NADAC has been published 59 times since Jul 9, 2025.

FDA first approved this application on Feb 12, 2025. Its Orange Book therapeutic-equivalence code is AN.

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)

Acetylcysteine
$2.1633per ML

Strength

200 mg/mL

NDC

70069001925

Classification

Generic

Dosage Form

SOLUTION

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Active Ingredients

ACETYLCYSTEINE

Approval Type

Generic (ANDA)

FDA Application

ANDA219194

FDA Approved

2/12/2025

TE Code

AN

On Market Since

3/4/2025

Pharmacological Classes

Antidote
Antidote for Acetaminophen Overdose
Decreased Respiratory Secretion Viscosity
Increased Glutathione Concentration
Mucolytic
Reduction Activity

Price Statistics

The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 59 times since Jul 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$2.1633 per ML
All-time high$2.6444 (Oct 15, 2025)
All-time low$2.1234 (Jul 9, 2025)
52-week high$2.6444
52-week low$2.1633
Median price$2.3886
Average price$2.3987
Largest weekly change+11.0% (Jul 23, 2025)
Weeks tracked59
Tracking sinceJul 9, 2025

Price History

1W

-3.0%

1M

-3.0%

3M

-8.8%

6M

-7.6%

1Y

-13.3%

3Y

N/A

5Y

N/A

All

+1.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Somerset Therapeutics, LLC, is $2.1633 per ML (NDC 70069001925), effective Aug 19, 2026.

How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?

Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has held within roughly two percent of its current level. It has been tracked across 59 weekly CMS publications since Jul 9, 2025.

What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

Since Jul 9, 2025, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $2.1234 (Jul 9, 2025) to a high of $2.6444 (Oct 15, 2025), with a median of $2.3886 per ML.

Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), is $0.7413 per ML — about 66% below ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION).

Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 70069001925) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.